Skip to content

Securing Cannulas in Combat: a simulation-based mixed method study

The S2C Study -Securing Cannulas in Combat: a simulation-based mixed method study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12621000314820
Acronym
S2C
Enrollment
30
Registered
2021-03-22
Start date
2021-04-26
Completion date
2021-08-27
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Haemorrhage is a significant cause of preventable death in combat settings. Clinical practice guidelines advocate for the rapid delivery of intravenous fluid bolus challenges for the hypovolemic trauma patient in the tactical environment. However, peripheral intravenous catheter (PIVC) insertion is challenging in the austere setting and failure is common. The aim of this study is to investigate dressing and securement methods that prevent catheter dislodgement and explore participants’ experiences with these devices within an Australian Defence Force tactical care of the casualty (TCCC) training course. A two phase mixed-method design will be used to compare the Ruggedised Field (Ranger) IV method to the S-Wrap technique to reduce PIVC dislodgement rates during TCCC simulations. The study will be undertaken at the Australian Army School of Health in Victoria, Australia. Observational data from this study will reveal securement techniques that optimise practice in high threat/disaster settings and enhance patient safety and quality.

Interventions

A pragmatic mixed-method design with two phases will be used to compare the Ranger IV method to the S-Wrap technique to reduce PIVC dislodgement rates during TCCC simulations. In Phase 1, the effectiveness of each method to prevent cannula dislodgement in vitro will be evaluated. Specifically, we will investigate the pull-out force in vitro of two PIVC securement methods. Pull-out force is defined in this study as the tensile force (N) required to produce PIVC dislodgement; this attempts to re

A pragmatic mixed-method design with two phases will be used to compare the Ranger IV method to the S-Wrap technique to reduce PIVC dislodgement rates during TCCC simulations. In Phase 1, the effectiveness of each method to prevent cannula dislodgement in vitro will be evaluated. Specifically, we will investigate the pull-out force in vitro of two PIVC securement methods. Pull-out force is defined in this study as the tensile force (N) required to produce PIVC dislodgement; this attempts to replicate how a PIVC administration line may become caught on a fixed object (e.g. tree branch, stretcher, body armour) in an austere combat setting. Pig skin (i.e. pork belly) will be used as a surrogate for human skin because it shares similar epidermal and dermal thickness ratios to human skin. In Phase 2, an observational audit of TCCC training will be conducted to understand the quality and safety of each method. At the completion of the final TCCC simulated practice scenario (approx 2 hour), focus groups with health care professionals will occur to explore their experiences of simulated PIVC insertion and securement practices. This study will be conducted in conjunction with existing defence health training courses and participants completing the simulated tactical care of the casualty course (TCCC) will be invited to participate. Due to the TCCC course requirements, all participants receive familiarisation training and will practise both the Ranger IV and S-Wrap PIVC securement methods and cannulate simulated casualties via a Laerdal™ training arm. During the combat field phase of TCCC course students who choose to participate in the study will be randomly allocated by their instructor to use either the Ranger IV method or the S-Wrap method. Consenting participants will have demographic data collected: e.g. rank, previous experience in cannulation, method approach used during TCCC, and current healthcare qualifications. The quality and safety of PIVC securement will be monitored, the recruitment target is 30 participants, and data collection will occur for each participant and to reach recruitment goal should take six months. Participants will be observed for evidence of PIVC insertion and securement complications using an observational field guide. The field guide has been developed for this study to focus observations and will be pilot tested prior to use. Maintaining situation awareness is a fundamental component of TCCC; thus, the time taken to complete the securement method will also be included in the field guide.

Sponsors

Army School of Health
Lead SponsorOther

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. All defence healthcare professionals (e.g. nurses, medical doctors, paramedics, combat medics) attending the TCCC will be eligible for participation.

Exclusion criteria

trainees < 18 years of age.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026